NO995959D0 - Modulatorer av intracellulaer inflammasjon, celledöd og celleoverlevelsesreaksjonsveier - Google Patents
Modulatorer av intracellulaer inflammasjon, celledöd og celleoverlevelsesreaksjonsveierInfo
- Publication number
- NO995959D0 NO995959D0 NO995959A NO995959A NO995959D0 NO 995959 D0 NO995959 D0 NO 995959D0 NO 995959 A NO995959 A NO 995959A NO 995959 A NO995959 A NO 995959A NO 995959 D0 NO995959 D0 NO 995959D0
- Authority
- NO
- Norway
- Prior art keywords
- cell
- modulators
- survival pathways
- cell death
- cell survival
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Credit Cards Or The Like (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12101197A IL121011A0 (en) | 1996-06-06 | 1997-06-05 | Modulators of intracellular cell death and cell survival pathways |
IL12119997A IL121199A0 (en) | 1997-06-05 | 1997-06-30 | Modulators of intracellular cell death and cell survival pathways |
IL12174697A IL121746A0 (en) | 1997-06-05 | 1997-09-11 | Modulators of intracellular cell death and cell survival pathways |
PCT/IL1998/000255 WO1998055507A2 (en) | 1997-06-05 | 1998-06-01 | Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain |
Publications (2)
Publication Number | Publication Date |
---|---|
NO995959D0 true NO995959D0 (no) | 1999-12-03 |
NO995959L NO995959L (no) | 2000-01-31 |
Family
ID=27271818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19995959A NO995959L (no) | 1997-06-05 | 1999-12-03 | DNA-sekvens, vektor, transformerte eukaryote eller prokaryote vertsceller, fremgangsmater for fremstilling av et protein, polypeptid, antistoff, fremgangsmate for isolering og identifisering, farmasoytisk sammensetning og fremgangsmate for screening. |
Country Status (15)
Country | Link |
---|---|
US (2) | US7374909B1 (no) |
EP (1) | EP0984983B1 (no) |
JP (1) | JP2002502258A (no) |
CN (1) | CN100451115C (no) |
AT (1) | ATE302215T1 (no) |
AU (1) | AU754963B2 (no) |
BR (1) | BR9809942A (no) |
CA (1) | CA2289479A1 (no) |
DE (1) | DE69831231T2 (no) |
DK (1) | DK0984983T3 (no) |
EA (1) | EA004658B1 (no) |
ES (1) | ES2244061T3 (no) |
IL (1) | IL121746A0 (no) |
NO (1) | NO995959L (no) |
WO (1) | WO1998055507A2 (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6482933B1 (en) * | 1998-02-06 | 2002-11-19 | Millennium Pharmaceuticals, Inc. | Molecules of the card-related protein family and uses thereof |
US6033855A (en) | 1998-02-06 | 2000-03-07 | Millennium Pharmaceuticals, Inc. | Genes encoding caspase recruitment domain polypeptides |
US6340576B1 (en) | 1998-02-06 | 2002-01-22 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules related to card-4L and CARD-4S |
US6680167B2 (en) | 1998-02-06 | 2004-01-20 | Millennium Pharmaceuticals, Inc. | Molecules of the card-related protein family and uses thereof |
US6469140B1 (en) | 1998-02-06 | 2002-10-22 | Millennium Pharmaceuticals, Inc. | Molecules of the card-related protein family and uses thereof |
US6096539A (en) * | 1999-06-10 | 2000-08-01 | Zeneca Limited | Protein activator of apoptosis |
US6953657B2 (en) | 1999-06-28 | 2005-10-11 | Millennium Pharmaceuticals, Inc. | Molecules of the CARD-related protein family and uses thereof |
US6756196B2 (en) | 1999-06-28 | 2004-06-29 | Millennium Pharmaceuticals, Inc. | Molecules of the card-related protein family and uses thereof |
AU1243601A (en) * | 1999-10-27 | 2001-05-08 | Millennium Pharmaceuticals, Inc. | Novel molecules of the card-related protein family and uses thereof |
US6936450B2 (en) * | 2000-04-12 | 2005-08-30 | Compugen Ltd. | Variants of protein kinases |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5578468A (en) * | 1987-08-10 | 1996-11-26 | Duke University | Site-specific RNA cleavage |
US5585479A (en) * | 1992-07-24 | 1996-12-17 | The United States Of America As Represented By The Secretary Of The Navy | Antisense oligonucleotides directed against human ELAM-I RNA |
EP0673252A4 (en) * | 1992-12-14 | 1998-07-15 | Start Technology Partnership | ADMINISTRATION OF ANTISENSE OLIGONUCLEOTIDES TO THE DOPAMIN RECEPTOR RNA MESSENGER FOR DIAGNOSING AND TREATING NEUROLOGICAL CONDITIONS. |
IL111125A0 (en) * | 1994-05-11 | 1994-12-29 | Yeda Res & Dev | Soluble oligomeric tnf/ngf super family ligand receptors and their use |
US6033855A (en) * | 1998-02-06 | 2000-03-07 | Millennium Pharmaceuticals, Inc. | Genes encoding caspase recruitment domain polypeptides |
-
1997
- 1997-09-11 IL IL12174697A patent/IL121746A0/xx unknown
-
1998
- 1998-06-01 DE DE69831231T patent/DE69831231T2/de not_active Expired - Fee Related
- 1998-06-01 DK DK98923042T patent/DK0984983T3/da active
- 1998-06-01 JP JP50199399A patent/JP2002502258A/ja not_active Ceased
- 1998-06-01 EP EP98923042A patent/EP0984983B1/en not_active Expired - Lifetime
- 1998-06-01 ES ES98923042T patent/ES2244061T3/es not_active Expired - Lifetime
- 1998-06-01 AU AU75467/98A patent/AU754963B2/en not_active Ceased
- 1998-06-01 CA CA002289479A patent/CA2289479A1/en not_active Abandoned
- 1998-06-01 CN CNB988057360A patent/CN100451115C/zh not_active Expired - Fee Related
- 1998-06-01 AT AT98923042T patent/ATE302215T1/de not_active IP Right Cessation
- 1998-06-01 EA EA199901117A patent/EA004658B1/ru not_active IP Right Cessation
- 1998-06-01 WO PCT/IL1998/000255 patent/WO1998055507A2/en active IP Right Grant
- 1998-06-01 BR BR9809942-6A patent/BR9809942A/pt not_active Application Discontinuation
- 1998-06-01 US US09/445,223 patent/US7374909B1/en not_active Expired - Fee Related
-
1999
- 1999-12-03 NO NO19995959A patent/NO995959L/no not_active Application Discontinuation
-
2005
- 2005-05-17 US US11/130,223 patent/US20050288225A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DK0984983T3 (da) | 2005-09-19 |
US20050288225A1 (en) | 2005-12-29 |
WO1998055507A3 (en) | 1999-03-11 |
DE69831231T2 (de) | 2006-06-08 |
ATE302215T1 (de) | 2005-09-15 |
NO995959L (no) | 2000-01-31 |
CA2289479A1 (en) | 1998-12-10 |
WO1998055507A2 (en) | 1998-12-10 |
EP0984983B1 (en) | 2005-08-17 |
CN1259165A (zh) | 2000-07-05 |
EP0984983A2 (en) | 2000-03-15 |
ES2244061T3 (es) | 2005-12-01 |
EA004658B1 (ru) | 2004-06-24 |
DE69831231D1 (de) | 2005-09-22 |
JP2002502258A (ja) | 2002-01-22 |
IL121746A0 (en) | 1998-02-22 |
EA199901117A1 (ru) | 2000-06-26 |
BR9809942A (pt) | 2000-08-01 |
AU754963B2 (en) | 2002-11-28 |
US7374909B1 (en) | 2008-05-20 |
CN100451115C (zh) | 2009-01-14 |
AU7546798A (en) | 1998-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1009832T3 (da) | Cytokin betegnet LERK-6 | |
ATE413386T1 (de) | Ppar-gamma modulatoren | |
DE69839313D1 (de) | Modifizierte vitamin k-abhängige polypeptide | |
ES2042693T3 (es) | Formulaciones proteinicas de plasma y recombinantes en medios de baja potencia ionica. | |
ATE320488T1 (de) | Mutanten des lag-3 proteins, ihre expression und verwendung | |
NO995959D0 (no) | Modulatorer av intracellulaer inflammasjon, celledöd og celleoverlevelsesreaksjonsveier | |
ATE286139T1 (de) | Replikationskompetente anti-tumor vektoren | |
NO20014537L (no) | AKT-nukleinsyrer, -polypeptider og anvendelse av disse | |
NO974179D0 (no) | Rekombinante viruser som uttrykker lecitin-kolesterol-acyltransferase, og anvendelse derav i genterapi | |
BG104769A (en) | Modulators of the function of receptors of the tnf/ngf receptor family and other proteins | |
NO971378L (no) | Cytokin betegnet LERK-6 | |
NO860907L (no) | Heterocykliske sulfider og deres anvendelse som immunmodulatorer. | |
HUT76971A (hu) | Az interleukin-1 béta konvertáló enzimmel rokon szerkezetű Tx- és Ty-emberi fehérjéket kódoló DNS-szekvenciák | |
IS4987A (is) | PTX næm G prótein, framleiðsla þeirra og notkun | |
DE60225530D1 (de) | Phosphorylierte glyoxalase i und deren verwendung | |
DK278290D0 (da) | Substituerede 6h-pyridooe4,3-baacarbazoler og deres anvendelse som laegemidler | |
DK1007672T3 (da) | Intracellulære glucocorticoid inducerede leucin zippermodulatorer af apoptotiske celledödsforlöb | |
ATE408687T1 (de) | Semaphorin polypeptide | |
SG148025A1 (en) | Modulators of the function of receptors of the tnf/ngf receptor family and other proteins | |
UA72877C2 (en) | Modulators of metabolic ways of intracellular inflammation, cells death and survival | |
DK578689D0 (da) | Renin-haemmende dipeptider, deres fremstilling og anvendelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |